AMRX Cash & Short-Term Investments
Amneal Pharmaceuticals Inc Class A · Cash & Short-Term Investments
AMRX Cash & Short-Term Investments
Latest reported$310.87Mperiod ending
AMRX FY Cash & Short-Term Investments ($66.06M → $310.87M)
Annual Cash & Short-Term Investments
High-resolution chart · PNG
AMRX cash & short-term investments history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 310,871,000 | |
| 112,420,000 | |
| 93,742,000 | |
| 27,797,000 | |
| 247,790,000 | |
| 343,074,000 | |
| 152,320,000 | |
| 213,394,000 | |
| 74,166,000 | |
| 31,721,000 | |
| 66,064,000 |